See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $784B | 15.9x | 40.7x | |
| $392B | 4.4x | 12.3x | |
| $368B | 6.4x | 14.3x | |
| $280B | 6.3x | 12.9x | |
| $149B | 6.2x | 19.6x | |
| $145B | 5.1x | 12.1x | |
| $141B | 3.0x | 14.2x | |
| $130B | 2.7x | 9.2x | |
| $121B | 10.7x | 54.4x | |
| $86.8B | 2.1x | 6.1x | |
| $83.2B | 5.5x | 16.4x | |
| $71.1B | 7.7x | 17.9x | |
| $57.2B | 1.1x | 5.4x | |
| $8.7B | 2.7x | 7.8x | |
| $7.4B | 9.8x | 37.6x | |
| $6.2B | 8.3x | n/a | |
| $5.7B | n/a | n/a | |
| $5.5B | 12.5x | 41.1x | |
| $4.8B | 5.8x | 21.8x | |
| $4.4B | 179.1x | -7.8x | |
| $3.2B | 14.1x | -5949.8x | |
| $1.8B | 1.8x | 9.0x | |
| $1.6B | 1.4x | 4.4x | |
| $1.6B | 36.3x | -3.6x | |
| $1.6B | 2.4x | 3.8x | |
| $1.5B | 622.7x | -4.3x | |
| $1.4B | 1.7x | 5.7x | |
| $1.2B | 1.0x | 3.0x | |
| $1.2B | 1.9x | 6.8x | |
| $1.2B | n/a | n/a | |
| $1.1B | 109.5x | -2.3x | |
| $998M | n/a | -6.4x | |
| $820M | 2.8x | 18.5x | |
| $805M | n/a | n/a | |
| $789M | 19.4x | -161.6x | |
| $744M | 2.2x | 25.8x | |
| $707M | 1.0x | 3.8x | |
| $613M | n/a | n/a | |
| $592M | 1.3x | 6.1x | |
| $558M | n/a | n/a | |
| $482M | n/a | -1.3x | |
| $449M | 6.4x | n/a | |
| $364M | 9.8x | -13.1x | |
| $354M | 1.1x | 6.8x | |
| $353M | 65.1x | n/a | |
| $348M | n/a | n/a | |
| $339M | n/a | -1.6x | |
| $330M | 7.0x | -5.0x | |
| $310M | n/a | -0.9x | |
| $307M | 29.7x | -1.9x | |
| $306M | 1.2x | 6.5x | |
| $291M | 43.9x | -3.3x | |
| $274M | 1.3x | -2.3x | |
| $235M | n/a | n/a | |
| $234M | 108.5x | -15.4x | |
| $198M | 0.5x | 1.6x | |
| $164M | 1.2x | -0.8x | |
| $162M | 13.8x | n/a | |
| $161M | 2.6x | -3.5x | |
| $161M | 5.7x | -0.7x | |
| $132M | 1.3x | 5.2x | |
| $127M | n/a | -3.6x | |
| $122M | 197.2x | -2.0x | |
| $110M | 90.5x | -4.7x | |
| $108M | n/a | -3.6x | |
| $107M | n/a | n/a | |
| $106M | 0.9x | 21.5x | |
| $105M | n/a | n/a | |
| $99.4M | 171.2x | n/a | |
| $73.4M | 2.6x | n/a | |
| $44.6M | n/a | n/a | |
| $43.8M | 5.5x | n/a | |
| $42.3M | 8.4x | -4.7x | |
| $36.1M | 1.4x | n/a | |
| $18.9M | 4.9x | n/a | |
| $16.3M | 20.2x | -8.8x | |
| $14.2M | n/a | n/a | |
| $13.6M | 8.2x | n/a | |
| $11.3M | 22.3x | n/a | |
| $2.2M | n/a | -0.1x | |
| -$3.3M | -0.3x | n/a | |
| -$7.4M | -0.4x | n/a | |
| -$15.5M | -29.6x | 0.3x | |
| -$18.6M | n/a | n/a | |
| -$24.4M | n/a | n/a | |
| -$38.7M | -0.3x | -1.7x | |
| -$44.5M | n/a | n/a | |
| -$46.4M | -2.0x | n/a | |
| -$51.6M | n/a | n/a | |
| -$52.6M | -2.9x | n/a | |
| -$72.1M | -119.6x | n/a | |
| -$79.0M | -43.7x | 1.4x | |
| -$96.6M | n/a | 0.6x | |
| -$115M | -11.8x | 0.7x | |
| -$220M | n/a | 0.8x | |
| -$259M | -216.0x | 1.3x |